Archive for March 2019
Predicting diagnosis and cognition with 18F-AV-1451 tau PET and structural MRI in Alzheimer’s disease
The relative importance of structural magnetic resonance imaging (MRI) and tau positron emission tomography (PET) to predict diagnosis and cognition in Alzheimer’s disease (AD) is unclear.
Read MoreArtificially low mild cognitive impairment to normal reversion rate in the Alzheimer’s Disease Neuroimaging Initiative
We examined reasons for low mild cognitive impairment (MCI)-to-cognitively normal (CN) reversion rates in the Alzheimer’s Disease Neuroimaging Initiative (ADNI).
Read MoreA rare missense variant of CASP7 is associated with familial late-onset Alzheimer’s disease
The genetic architecture of Alzheimer’s disease (AD) is only partially understood.
Read MoreDietary changes and cognition over 2 years within a multidomain intervention trial—The Finnish Geriatric Intervention Study to Prevent Cognitive Impairment and Disability (FINGER)
Association between healthy diet and better cognition is well established, but evidence is limited to evaluate the effect of dietary changes adopted in older age.
Read MoreSubjective cognitive decline and rates of incident Alzheimer’s disease and non–Alzheimer’s disease dementia
In this multicenter study on subjective cognitive decline (SCD) in community-based and memory clinic settings, we assessed the (1) incidence of Alzheimer’s disease (AD) and non-AD dementia and (2) determinants of progression to dementia.
Read MoreGenetic screen in a large series of patients with primary progressive aphasia
Primary progressive aphasia (PPA) is a neurological syndrome, associated with both frontotemporal dementia and Alzheimer’s disease, in which progressive language impairment emerges as the most salient clinical feature during the initial stages of disease.
Read More